NASA Announces Three Commercial Suppliers for New Lunar Lander

The three companies selected by NASA: SpaceX, Dynetics, and the Blue Origin National Team.

New Decision Highlights Commercial Suppliers on an Aggressive Schedule

NASA has shown great wisdom in selecting three technologically different architectures for its Human Landing System to increase its chances for success.”

— Dale Skran, Chair of the NSS Executive Committee

WASHINGTON, D.C., US, April 30, 2020 /EINPresswire.com/ — The National Space Society (NSS) applauds NASA’s April 30 announcement by NASA Administrator James Bridenstine that SpaceX, Dynetics, and Blue Origin’s National Team have been chosen to provide human landing systems to carry crew to the Moon for Artemis III, the third phase of the Artemis lunar program. These commercial entities represent three different architectures for landing humans on the Moon. SpaceX’s giant Starship, capable of carrying 100 tons to the Moon, is a single-stage approach. A two-stage architecture will be developed by Dynetics in coordination with Sierra Nevada Corporation. Finally, Blue Origin’s National Team, consisting of Northrop Grumman, Lockheed Martin, and Draper, has plans to develop a three-stage architecture to return humans to the Moon.

“We have great companies that have invested many of their own resources into this great effort,” Bridenstine said. “So much work has already happened … we are going to the moon, with commercial partners … and ultimately, the goal is to get to Mars.” Bridenstine added, “Some contractors might focus on speed while others focus on sustainability more,” an additional indication that NASA is in for the long-term.

NSS Chair of the Executive Committee Dale Skran said, “NASA has shown great wisdom in selecting three technologically different architectures for its Human Landing System to increase its chances for success. It is especially exciting to see that for the first time NASA is officially including the SpaceX Starship/SuperHeavy in a major project. This is the right program structured the right way, with NASA allowing competing companies to design the human landers with mission-appropriate oversight, and then to provide NASA with lunar landing services without NASA owning the landers.” NSS Executive Vice President Alfred Anzaldúa added, “Today NASA again shows its deep commitment to achieving its goal of sending humans to the Moon and continuing to Mars in the most cost-effective and sustainable manner possible. This decision aligns with the NSS’s Roadmap to Space Settlement by supporting the use of commercial entities in returning to the Moon.”

It is noteworthy that NASA officials made it clear that they would be carefully considering design specifications to avoid delays due to changing requirements on the space agency’s end.

Artemis III is slated to take place after the Artemis I uncrewed flight test, carried out by NASA’s Space Launch System (SLS) rocket and Orion spacecraft, followed by Artemis II, a crewed flight by SLS and Orion. The overall aim of the Artemis Program is to deliver the first woman and next man to the lunar surface by the end of 2024, with the intention of maintaining a U.S. presence there indefinitely. The NASA press release can be seen here.

The National Space Society was founded in 1987 via a merger of the National Space Institute, founded by NASA’s Wernher von Braun, and the L5 Society, based on the work of space settlement pioneer Gerard K. O’Neill. It is the world’s largest pro-human-spaceflight organization.

To learn more about the NSS and its mission to establish humanity as a spacefaring species, visit us on the web at space.nss.org.

Alfred Anzaldua
National Space Society
email us here
+1 520-409-5797


Source: EIN Presswire

SDVOSB Maness Veteran Medical is Yankaddy's Exclusive Partner for VA and DoD Facilities

MVM is proud to have a hand in protecting our healthcare workers and patients through the distribution of the Yankaddy.

ASHEVILLE, NC, UNITED STATES, April 30, 2020 /EINPresswire.com/ — SDVOSB Maness Veteran Medical is proud to announce a brand new exclusive partnership
with Yankaddy®! This game-changing product is designed to help prevent healthcare
associated infections (HAIs) commonly spread by the yankauer suction instrument on surfaces
in the healthcare workplace. According to the CDC, 1.7 million patients are affected each year
in the US by HAIs. The Yankaddy® can change that.

A true revolutionary product, the Yankaddy® is the solution to storage issues of the yankauer
suction instrument before, during, and after its use on a patient.

The Yankaddy® offers a reliable place to store the yankauer suction instrument thereby
keeping the environment from becoming contaminated. Designed to be used with one hand, the
Yankaddy® adds safety to patients and convenience to medical providers. The lightweight
storage brackets and holster may be clamped or suctioned to most surfaces in a room. The
system features a disposable lid/liner making the Yankaddy® the ultimate patient safety tool,
allowing healthcare providers to focus on their duties, putting Infection Control At Your
Fingertips®!

As always, Maness Veteran Medical’s overwhelming concern is bringing the world’s best
products to the veterans, and quickly. The Yankaddy® will not only help these veterans, but also
the wonderful caregivers assisting them daily.

Please reach out today for samples, or to place an order with MVM!

Johnathan Maness
Maness Veteran Medical, LLC (SDVOSB)
+1 833-367-6778

Johnathan Maness
Maness Veteran Medical
+1 7274525452
email us here
Visit us on social media:
LinkedIn

The Yankaddy


Source: EIN Presswire

Nathan Heddleston: Running Keeps Life Worth Living

Nathan Heddleston Teacher

Nathan Heddleston

ALLIANCE, OHIO, USA, April 30, 2020 /EINPresswire.com/ — Nathan Heddleston has seen many people struggle to stay happy and healthy in an increasingly complicated world. But in his role as Nathan Heddleston teacher to many individuals, Heddleston has found that running provides an incredible array of benefits that make life worth living.

Nathan Heddleston Teacher Uses Running to Stay Fit

As we age, Nathan Heddleston says, it is very easy to start to gain weight. Most people stop exercising and let themselves go in a way that can be very problematic. But in his role as Nathan Heddleston teacher he has found that encouraging people to run helps them stay in great shape. Heddleston has used running to fight off the battle of the bulge and to keep as fit as possible late into life.

Just as importantly, Nathan Heddleston teacher has found that running helps to keep the body fit in ways that other exercises cannot. For example, he states that running keeps his cardiovascular health secure and balances his cholesterol, blood pressure, and much more. However, he also says that people need to work up to "running" with walking and jogging to avoid hurting themselves by straining their bodies too much.

Running May Help Make New Connections

In his role as Nathan Heddleston teacher, he has found that running is a great way to connect with others. Simply put, runners often stick together because so few people are willing to perform this type of exercise. And making new connections is something that he emphasizes in his role as Nathan Heddleston teacher. Humans are social creatures, he says, who need individual bonds.

And people find them in many ways – religion, politics, work, and hobbies all help bring people together. And in his role as Nathan Heddleston "teacher," he has found that running helps connect people who may not otherwise get along. For example, he has found that people on the opposite sides of the political spectrum may run together and create friendships that last for years.

Running Enhances a Person's Well Being

When working as Nathan Heddleston teacher he has found that running has helped many of his students and compatriots fight of many symptoms of depression and anxiety. While Heddleston understands that medical and psychological treatment are essential for these emotional troubles, he also knows that running can help many people heal by activating endorphin chemicals.

This situation, known as "the runner high," is something that he says he achieves every time he goes for a run. These feelings are critical to his role as Nathan Heddleston teacher because they help his students calm their minds, relax their nerves, and feel better about life. Just as importantly, running takes people outside and into a more natural environment. And in his role as Nathan Heddleston "teacher", he suggests running on a wooded trail, if possible, to enhance this benefit even further.

Caroline Hunter
Web Presence, LLC
+1 786-233-8220
email us here

Nathan Heddleston Teacher


Source: EIN Presswire

AOAC INTERNATIONAL Scientists Approve Confirmatory Screening Test for Detecting Veterinary Drug Residues in Foods

AOAC INTERNATIONAL logo

New Official Method expected to facilitate safety testing of products in the global marketplace

ROCKVILLE, MARYLAND, USA, April 30, 2020 /EINPresswire.com/ — AOAC INTERNATIONAL today announced approval of a new First Action Official Method of Analysis℠ that can streamline screening for residues of 154 veterinary drugs in a broad range of animal food products.

Developed and submitted by scientists at Nestlé Research (Lausanne, Switzerland) in response to an AOAC Call for Methods, the liquid chromatography tandem mass spectrometry approach is applicable for screening and confirming 105 antibiotic, 41 antiparasitic, 5 anti-inflammatory agents, and 3 tranquilizers in a broad range of food products, including milk-, meat-, and fish-based ingredients and processed products (skimmed milk powder, fat-filled milk powder, whey protein, lactose, casein, infant formula, infant cereals, and baby foods, among others). The method was approved on April 24, 2020, during AOAC’s Analytical Methods Week.

Consumers have increasingly become concerned about veterinary drug residues in food, even more so with the high-profile issue of antimicrobial resistance emphasized by the World Health Organization. But controlling veterinary drug residues in the food sector is challenging due to the large number of drugs administered to food source animals, the diversity of animals and derived products, and a complex international regulatory environment.

“As the first multi-residue laboratory method to receive AOAC’s Official Method designation, this is a milestone in the veterinary drug residue analytical community,” said Dr. Joe Boison, chair of the Expert Review Panel that approved the method.

More than 200 compounds from veterinary drugs have been identified as presenting a potential health risk for consumers and are regulated at the national level or internationally through global food standards organizations. Most are regulated based on maximum residue limits, while some are banned for human consumption in food. Reliable analytical solutions are needed to monitor these substances in a wide range of food commodities. Several confirmatory methods based on liquid chromatography mass spectrometry are available, but they are more limited in the scope of food products, or matrices, they can be used with.

Research in the U.S. and the European Union indicates that rates of veterinary drug residue non-compliance are generally low, so the goal of this method was to provide food companies and regulators with an efficient pass/fail screen to increase throughput together with reliability. Samples flagged as suspect can then be analyzed for quantitation.

“Nestlé produces an enormous variety of food and has 21 control laboratories worldwide equipped with mass spectrometry instruments. We needed a more cost-effective method that could screen across a broad range of matrices,” explained Thierry Delatour, Group Leader at Nestlé Research and one of the method’s authors.

Critically for the food industry, the screening tool is well adapted to the global supply chain that includes not just raw materials such as milk, but also derivatives, such as milk powders that are heavily traded worldwide.

Dr. Boison added, “Once this method achieves Final Action status, we expect it to be very valuable in dispute resolution cases to facilitate international trade involving food animal products.”

Official Methods of Analysis of AOAC INTERNATIONAL are microbiological and chemical analysis procedures that have undergone rigorous formal validation by AOAC INTERNATIONAL. After a two-year tracking period, “First Action” methods are reviewed for approval as “Final Action” methods, which are published in the Official Methods of Analysis of AOAC INTERNATIONAL, a globally recognized standards resource for analytical scientists.

The approval of this method is the result of a multi-year community effort that was initiated with Nestlé to meet the need for a reliable confirmatory screening test. Managed by AOAC from inception to conclusion, the project included a year-long effort to develop a global stakeholder consensus on Standard Method Performance Requirements (SMPR®) for the more than 150 drug residues covered, and their residue limits in various commodities. The SMPR development was supported in part by Nestlé, Abbott Nutrition, Fonterra, Thermo Scientific, and Tyson Corporation.

The method was evaluated against SMPR 2018.010 which details the criteria needed for a valid screening and identification method for regulated veterinary drug residues in food.

“The volunteers on the Working Group, the Expert Review Panel and the AOAC staff were highly committed and it was a pleasure to work with them,” said Thierry Delatour. “Everyone was aware of the challenges and agreed on what direction to go. It was a very clear and fruitful process.”

"Screening 154 Veterinary Drug Residues in Animal Source Foods by LC-MS/MS” will be published in the Journal of AOAC INTERNATIONAL and Official Methods of Analysis.

For more information, please contact Deborah McKenzie, AOAC INTERNATIONAL Senior Director of Standards, at dmckenzie@aoac.org.

###

About AOAC INTERNATIONAL

AOAC INTERNATIONAL is a globally recognized, 501(c)(3), independent, third party, not-for-profit association and voluntary consensus standards developing organization founded in 1884. When analytical needs arise within a community or industry, AOAC INTERNATIONAL is the forum for finding appropriate science-based solutions through the development of microbiological and chemical standards. The AOAC Official Methods of Analysis database is used by food scientists around the world to facilitate public health and safety and to promote trade. For more information please visit www.AOAC.org.

Marida Hines
AOAC INTERNATIONAL
+1 240-912-1445
email us here
Visit us on social media:
LinkedIn
Twitter
Facebook


Source: EIN Presswire

Dr. Eugene Gu Fights Smoking Addiction with Startup CoolQuit Company

Dr. Eugene Gu

Dr. Eugene Gu Cool Quit

LOS ANGELES, CA, USA, April 30, 2020 /EINPresswire.com/ — Cofounders Dr. Eugene Gu and Dr. Bhargav Raman formed the startup company Cool Quit to help U.S. patients fight the battle of smoking addiction. Over 480,000 Americans die from smoking-related deaths each year. That's one in five American deaths – more than diabetes, drug abuse, alcohol, vehicle accidents, and gun violence combined. Smoking harms nearly every organ of the body, according to the U.S. Center for Disease Control. It's also the leading cause of preventable death.

Cool Quit was Founded in January 2020

Founded in January 2020, Cool Quit helps provide patients with affordable options to quit smoking. The products and services are usually free of charge with most health insurance policies. Uninsured patients have access to them via a modest subscription fee. For those who cannot afford the fee, patients can move forward with a fee waiver application process.

Studies show that smokers who quit greatly improve their health, even if they quit smoking later in life. Health benefits of quitting begin in as little as 20 minutes after taking the last cigarette. The risk of heart attack drops by 50% after one year smoke-free, and within five years the risk of bladder, esophagus, mouth, and throat cancer is cut in half. In a 2015 national study, 7 out of 10 adult smokers desired to quit smoking. In 2018, more than half of U.S. smokers tried to quit altogether.

Dr. Eugene Gu is Passionate About Saving Lives

"We are honored to lead a multidisciplinary team of primary care doctors, addiction specialists, nurse practitioners, and physician assistants to get our patients and the American people off the tobacco products that are killing them every day," says Dr. Eugene Gu. "I'm really passionate about saving lives using evidence-based medicine in particular, to help the most vulnerable. I don't regret it, it's a hard job but it's what I wanted to do."
Both Drs. Eugene Gu and Bhargav Raman are reputed graduates from Stanford University with honors. They are licensed to practice in several states and also in telemedicine. Gu mentioned that the number of patients Cool Quit serves is constantly growing. The company is working on being licensed to serve in as many U.S. states as possible. For doctors who are interested in joining the Cool Quit team to help provide medical services, contact Cool Quit to learn more about hiring inquiries. U.S. citizens who are interested in smoking cessation are encouraged to visit CoolQuit.com to get started.

Caroline Hunter
Web Presence, LLC
+1 786-233-8220
email us here
Visit us on social media:
Twitter
LinkedIn

Dr. Eugene Gu Dog Walk Trump


Source: EIN Presswire

Meadowlark Optics acquires ICE CubeTM product line from MOXTEK

ICE Cube Wire Grid Beam Splitting Polarizer

ICE Cube Wire Grid Beam Splitting Polarizer

Acquisition Expands Meadowlark’s Polarization Solutions Offerings

FREDERICK, CO, UNITED STATES, April 30, 2020 /EINPresswire.com/ — Meadowlark Optics, Inc. (Meadowlark) today announced that it has acquired the wire-grid ICE Cube™ polarizing beam splitting (PBS) cube product line from MOXTEK, Inc. (Moxtek). The acquired product line will enable Meadowlark to expand on its existing wire-grid and polarization optics products.

“This is a great addition to our family of polarizers,” said Garry Gorsuch, President and CEO of Meadowlark Optics. “We have been working with Moxtek for many years and their wire-grid polarizer technology is a perfect fit with our best-in-class polarization solutions business.”

Meadowlark has purchased the remaining ICE Cube stock from Moxtek and will continue to manufacture the PBS cube going forward. The ICE Cube polarizer performance exceeds that for the commonly used thin film MacNeille cubes in both acceptable wavelength range and angle of incidence range while providing more than twice the contrast ratio in the transmitted beam for most wavelengths. It is optimized for use over a wide range of acceptance angles while maintaining color uniformity and image contrast in the visible and IR wavelength spectrums. The cube allows compact optical designs with reduced optical paths. Engineers are now able to design smaller systems while maintaining excellent optical performance.

Shaun Ogden of Moxtek stated, “We are excited to hand this product over to Meadowlark who is a trusted leader in optical assembly and polarization solutions. We know Meadowlark Optics will handle this product with the respect it deserves.”

About Meadowlark
Meadowlark Optics, located in Frederick, CO, manufactures polarization solution components including liquid crystal shutters, rotators and spatial light modulators for wavelengths ranging from the UV to the MWIR. OEM customers and researchers world-wide use the products in a variety of applications including microscopy, aerospace, defense, telecommunications, automotive, semiconductor manufacturing, medical devices and more. To ensure precision and top quality, our 20,000 SF headquarters boasts the latest in clean rooms, optical fabrication, and metrology facilities. www.meadowlark.com.

About Moxtek
MOXTEK®, located in Orem, Utah, manufactures high performance components for analytical x-ray instrumentation and optical systems. Their inorganic Nanowire® optical polarizers & polarizing beam splitters are ideal for applications that require broadband wavelengths, heat tolerance, and large angles of incidence. Our UV-VIS-IR polarizers are used for a variety of application including: 2D & 3D projection display, machine vision, HMD, HUD, polarimetry, medical/dental imaging, interferometry, spectroscopy, and many others. www.moxtek.com.

###

Kelly Gregorak
Meadowlark Optics
+1 303-833-4333
email us here


Source: EIN Presswire

42% of US consumers think news about the seriousness of COVID-19 is “exaggerated” – GfK

92% consider themselves well informed about COVID-19 – but 67% say it is becoming hard to tell “fake” virus news from real

NEW YORK, NY, UNITED STATES, April 30, 2020 /EINPresswire.com/ — While most of the US remains on some form of lockdown this week, many Americans say they still have doubts about the news they are receiving on COVID-19.

In a new GfK study, four in ten Americans (42%) agree either strongly or somewhat with the statement, “I think the news about the seriousness of coronavirus has been exaggerated.” This includes half (49%) of all US men – compared to just 35% of women. Men are also twice as likely as women to strongly agree that news about the virus is exaggerated (23% vs 12%).

Click here to register for a May 7th webinar on this study

Other groups with a 50% or greater rate of agreement (strongly or somewhat) are US consumers who:
• are in the 36-to-50 age range: 50% (versus 31% of those 51 to 65)
• have some level of higher education: 50% (versus 38% of those with lower education levels)
• reside in large urban metropolises: 59% (versus 32% for those in small cities)

The research – conducted April 24th to 27th as part of GfK’s global Consumer Pulse studies – also shows that 67% of Americans feel strongly or somewhat that, “When people talk about coronavirus, it’s getting harder to distinguish between accurate news and fake news.”

Yet 92% consider themselves well-informed about the virus—up slightly from 88% in the previous wave of the study. Exploring specific sources of news, 60% of Americans say they “feel better informed about coronavirus because of news I get from the Internet.” This is below television (66%) but above newspapers (58%) and the radio (51%).

GfK’s Consumer Pulse research covers 30 countries, allowing brands and marketers to #MasterTheCrisis by understanding consumer attitudes, behavior, purchase intent, media consumption, and more – both now and in the future. The research reveals changes in demand for goods and services, as well as which sectors and channels present risks or opportunities, so that companies can respond with confidence and come out of the crisis stronger, better positioned, and closer to consumers than before.

As part of this research, GfK interviewed a representative sample of 1,019 US consumers (ages 15 and up) during the week of April 24 to 27, 2020.

GfK – extracting the signals from the noise

In a world of data overflow, disruption and misuse, picking up the right “signal from noise” is key to win. We at GfK are the trusted partner and have more than 85 years of experience in combining data and science to help you make the right business decisions. Together with our attention to detail and advanced Augmented Intelligence, we provide you with world-class analytics that delivers not just descriptive data but actionable recommendations always-on at your fingertips. As a result, you can make key business decisions with confidence which help you drive sales, organizational and marketing effectiveness. That’s why we promise to you “Growth from Knowledge.”
For more information, please visit www.gfk.com/en-us or follow GfK on Twitter www.twitter.com/GfK.

David Stanton
GfK
+1 908 875 9844
email us here


Source: EIN Presswire

Global HP (High Potency) APIs Market Size, Segments, And Growth Rate

The Business Research Company HP (High Potency) APIs Market Global Report 2020-30: Covid 19 Impact And Recovery

LONDON, GREATER LONDON, UK, April 30, 2020 /EINPresswire.com/ — The global high potency APIs (HPAPI) market is expected to decline from $19.7 billion in 2019 to $18.5 billion in 2020 at a rate of about -6%. The decline is mainly due to the focus on the COVID-19 outbreak and its treatment across the globe, resulting in patients of other illnesses (including cancer and other immunodeficiency diseases) delaying their episodes of care, as well as restrictions on trade and exports owing to the lockdown of countries that manufacture the drug. The market is then expected to recover and reach $24.1 billion in 2023 at a rate of 5.2%. The rising number of cancer cases coupled with increasing sales of cancer drugs contributed to the growth of the high potency APIs market.

However, high investment requirements are anticipated to restrain the growth of the market over the coming years.
The high potency APIs (HPAPI) market consists of sales of high potency active pharmaceutical ingredients and related services. High potency APIs are extremely effective in pharmacologically active ingredients. These are highly specific in their action and offer significant efficiency even at the low daily therapeutic doses. HPAPIs are used in formulations for high potent drugs, owing to their ability to target precise disease cells including cancer cells.

Request For A Free Sample For The Global HP (High Potency) APIs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2814&type=smp

The global HP APIs market is further segmented based on type and geography.

By Type – Innovative HPAPI; Generic HPAPI

By Synthesis Type – Synthetic HPAPI; Biotech HPAPI

By Therapeutic Application – Oncology; Hormonal Disorder; Glaucoma; Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction)

By Geography – The global HP APIs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global HP (High Potency) APIs Market At:
https://www.thebusinessresearchcompany.com/report/hp-high-potency-apis-market-global-report-2020-30-covid-19-impact-and-recovery

Trends In The HP (High Potency) APIs Market

The companies dealing in the high potency APIs market are focusing on strategies such as production facility expansion and mergers & acquisitions to maintain their position in a competitive business environment.

HP (High Potency) APIs Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides HP APIs market overviews, analyzes and forecasts HP APIs market size and growth for the global HP APIs market, HP APIs market share, HP APIs market players, HP APIs market size, HP APIs market segments and geographies, HP APIs market trends, HP APIs market drivers and HP APIs market restraints, HP APIs market’s leading competitors’ revenues, profiles and market shares. The HP APIs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More

Read HP (High Potency) APIs Global Market Report 2020 from The Business Research Company for information on the following:

Markets Covered: Global HP (High Potency) APIs Market

Data Segmentations: HP (High Potency) APIs Market Size, Global And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

HP (High Potency) APIs Market Organizations Covered: Eli Lily and Company, Novartis AG, Bristol-Myers Squibb Company, Roche Diagnostics Ltd., Sanofi, Hospira, Inc., BASF SE, Covidien plc, Boehringer Ingelheim GmbH and Merck & Co., Inc.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa
Time Series: Five years historic (2015-19) and forecast (2019-23)

Other Information And Analyses: PESTEL analysis, HP APIs market customer information, HP APIs market product/service analysis – product examples, HP APIs market trends and opportunities, drivers and restraints, key mergers and acquisitions, key metrics covered: number of enterprises, number of employees, global HP APIs market in 2020 – countries offering most new opportunities.

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The HP (High Potency) APIs Industry: The report explains a number of strategies for companies in the HP APIs market, based on industry trends and company analysis.

Opportunities For Companies In The HP (High Potency) APIs Sector: The report reveals where the global HP APIs industry will put on most $ sales up to 2023.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the HP (High Potency) APIs Global Market Report 2020:

Pharmaceutical API Manufacturing Global Market Report 2020

Cancer Diagnostics Global Market Report 2020

Cancer Biologics Global Market Report 2020

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Global Drug Delivery Devices Market Trends And Strategies

Global Drug Delivery Devices Market Size, Definition, and Segments.

Global Drug Delivery Devices Market

The Business Research Company's Latest Study On The Drug Delivery Devices Market.

LONDON, GREATER LONDON, UK, April 30, 2020 /EINPresswire.com/ — The global drug delivery devices market is expected to grow from $1.4 billion in 2019 to about $1.6 billion in 2020 as there is a marginal increase in demand due to the use of such devices in the treatment of COVID-19 patients. The market is expected to stabilize and reach $1.9 billion at a CAGR of 8.2% through 2023. Drugs used for COVID-19 treatment are both oral and injectable; however, a marginal increase is expected for pulmonary or respiratory-based drug delivery devices. However, regulatory changes related to medical devices is expected to restraint the growth of the drug delivery devices market.

The drug delivery devices market consists of the sales of medical devices and equipment that are used for delivering specific drugs to a specific part of the body to cure chronic diseases such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases. The market includes the sales of the devices that are specifically made for delivering specific drugs according to the various administration techniques of oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery and implantable drug delivery. Drug delivery devices used in various patient care settings such as hospitals, diagnostic centers, pharmaceutical companies, clinics and home care settings are included in this market.

Request For A Free Sample For The Global Drug Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

The global drug delivery devices market is further segmented based on type and geography.

By Route Of Administration – Oral Drug Delivery; Injectable Drug Delivery; Topical Drug Delivery; Ocular Drug Delivery; Pulmonary Drug Delivery; Nasal Drug Delivery; Transmucosal Drug Delivery; Implantable Drug Delivery

By Patient Care Setting – Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Home Care Settings; Others
By Application – Cancer; Infectious Diseases; Respiratory Diseases; Diabetes; Cardiovascular Diseases; Autoimmune Diseases; Central Nervous System Disorders; Others

By Geography – The global drug delivery devices market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, Asia-Pacific is forecasted to register the highest growth rate in the drug delivery devices market through 2023.

Read More On The Report For The Global Drug Delivery Devices Market At:
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market-global-report-2020-2030-covid-19-implications-and-growth

Trends In The Drug Delivery Devices Market

The microneedle (MN) is a highly efficient and versatile medical device technology due to its prominent properties including painless penetration, low cost, excellent therapeutic efficacy, and relative safety. This novel delivery method allows a wider variety of molecules to pass the skin’s barrier, thus allowing transdermal delivery to be applied to a large range of clinical applications including diabetes, severe osteoporosis, and influenza vaccinations.
Drug Delivery Devices Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides drug delivery devices market overviews, analyzes and forecasts drug delivery devices market size and growth for the global drug delivery devices market, drug delivery devices market share, drug delivery devices market players, drug delivery devices market size, drug delivery devices market segments and geographies, drug delivery devices market trends, drug delivery devices market drivers and drug delivery devices market restraints, drug delivery devices market’s leading competitors’ revenues, profiles and market shares. The drug delivery devices market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More

Read Drug Delivery Devices Global Market Report 2020 from The Business Research Company for information on the following:

Markets Covered: Global Drug Delivery Devices Market

Data Segmentations: Drug Delivery Devices Market Size, Global And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Drug Delivery Devices Market Organizations Covered: F. Hoffmann-La Roche Ltd, 3M Company, Pfizer Inc., Baxter International, BD., Novartis AG, Gerresheimer AG, Johnson & Johnson Services, Inc., Bayer AG, GlaxoSmithKline plc.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa

Time Series: Five years historic (2015-19) and forecast (2019-23)

Other Information And Analyses: PESTEL analysis, drug delivery devices market customer information, drug delivery devices market product/service analysis – product examples, drug delivery devices market trends and opportunities, drivers and restraints, key mergers and acquisitions, key metrics covered: number of enterprises, number of employees, global drug delivery devices market in 2020 – countries offering most new opportunities

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Drug Delivery Devices Industry: The report explains a number of strategies for companies in the drug delivery devices market, based on industry trends and company analysis.

Opportunities For Companies In The Drug Delivery Devices Sector: The report reveals where the global drug delivery devices industry will put on most $ sales up to 2023.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the Drug Delivery Devices Global Market Report 2020:

Injectable Drug Delivery Devices Global Market Report 2020-30: COVID-19 Impact and Recovery

Pharmacies and Healthcare Stores Global Market Report 2020-30: COVID-19 Impact and Recovery

Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) – Global Forecast To 2021

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Cyber Weapons Technologies Market 2020 – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2025

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

PUNE, MAHARASTRA, INDIA, April 30, 2020 /EINPresswire.com/ — Report Overview

A comprehensive analysis based on key parameters has been presented by the report published on the Cyber Weapons Technologies market. Using the data from 2020 to 2025, the report presents the market status and size in a forecast study. This presents the overall market valuation along with the CAGR for the forecast period. The introductory chapter of the report presents an overview of the Cyber Weapons Technologies market along with the product definition and market scope. The consumer trends regarding the products along with the industry development trends have been analyzed to provide insights on the market. 

This report studies the global Cyber Weapons Technologies market, analyzes and researches the Cyber Weapons Technologies development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2802333-global-cyber-weapons-technologies-market-size-status-and-forecast-2025

This report focuses on the top players in global market, like
BAE Systems
Boeing
General Dynamics
Lockheed Martin
Northrop Grumman
EADS Group
Immunity Inc
Israel Aerospace Industries (IAI)
Vupen Security
AVG Technologies
Avast Software
Bull Guard Ltd
F Secure Labs
Kaspersky Lab
Symantec Corporation
Trend Micro
Mandiant

Segmental Analysis

The market study contains the division of the overall market into different regional segments according to the key geographic regions. The whole of the Honeymoon Tourism market has been covered with regards to the key countries and regions. Using the results from the regional analysis, the report also presents a forecast for the local markets. All the major regions in the market have been covered with broad segments including North America, South America, Asia-Pacific, the Middle East, Europe, and Africa. The other major segmentations on the market cover the product types and end-user applications.

Regional analysis:

The report provides a comprehensive regional analysis taking various aspects in to account. Here the key players have been identified understanding the strategies applied by them. In concurrence, the partnership level can be analysed, along with the associated factors or scopes to merge. Here the key markets like Asia Pacific, Europe, and the Middle East & Africa has been taken in to account. The report makes prediction of the market up to 2025

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Table of Contents

Global Cyber Weapons Technologies Market Size, Status and Forecast 2025
1 Industry Overview of Cyber Weapons Technologies
1.1 Cyber Weapons Technologies Market Overview
1.1.1 Cyber Weapons Technologies Product Scope
1.1.2 Market Status and Outlook
1.2 Global Cyber Weapons Technologies Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Cyber Weapons Technologies Market by Type
1.3.1 Defensive Cyber Weapons
1.3.2 Offensive Cyber Weapons
1.3.3 Offensive and Defensive Cyber Weapons
1.4 Cyber Weapons Technologies Market by End Users/Application
1.4.1 Defense
1.4.2 Homeland Security
1.4.3 Other

2 Global Cyber Weapons Technologies Competition Analysis by Players
2.1 Cyber Weapons Technologies Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 BAE Systems
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Cyber Weapons Technologies Revenue (Million USD) (2013-2018)
3.1.5 Recent Developments
3.2 Boeing
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Cyber Weapons Technologies Revenue (Million USD) (2013-2018)
3.2.5 Recent Developments
3.3 General Dynamics
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Cyber Weapons Technologies Revenue (Million USD) (2013-2018)
3.3.5 Recent Developments
3.4 Lockheed Martin
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Cyber Weapons Technologies Revenue (Million USD) (2013-2018)
3.4.5 Recent Developments
3.5 Northrop Grumman
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Cyber Weapons Technologies Revenue (Million USD) (2013-2018)
3.5.5 Recent Developments
3.6 EADS Group
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Cyber Weapons Technologies Revenue (Million USD) (2013-2018)
3.6.5 Recent Developments
3.7 Immunity Inc
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Cyber Weapons Technologies Revenue (Million USD) (2013-2018)
3.7.5 Recent Developments

……Continued

Make an enquiry of this Report @ https://www.wiseguyreports.com/enquiry/2802333-global-cyber-weapons-technologies-market-size-status-and-forecast-2025

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire